TCL Archive Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation February 29, 2008
TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014